Avalon GloboCare (US:ALBT) Globenewswire·2025-12-01 14:00Core Insights - Avalon GloboCare Corp. announced significant advancements for its KetoAir™ product in Q3 2025, including expanded deployment, a first-responder metabolic health program, and entry into international markets [1][3] Product Development - KetoAir™ is a handheld breathalyzer designed for ketogenic health management, measuring breath acetone concentration (BrAce), which indicates fat metabolism and ketosis [3] - The device is FDA-registered as a Class I medical device and is compatible with both Apple and Android devices, available for purchase through the Apple App Store and Google Play Store [3][5] Market Expansion - Avalon launched the KetoAir™ in the United Kingdom on September 1, 2025, marking its first international expansion [7] - The company showcased KetoAir™ at the London Health Optimization Summit on September 13-14, 2025, highlighting its integration into wellness and metabolic health programs [7] Health Initiatives - In August 2025, Avalon, in collaboration with Saga Health and SpecialtyHealth, launched the "Nevada POOL/PACT Holistic Health Reset" program for 50 first responders, utilizing KetoAir™ for daily monitoring of metabolic changes [7] - Mid-program results from the Nevada initiative indicated individual improvements in metabolic health, potentially driven by better diet, exercise, and sleep quality [7]